End-of-day quote
Other stock markets
|
||
- USD | - |
04-22 | 3Sbio Inc. Announces Management Changes | CI |
04-15 | 3SBIO Gets China Nod for Use of Cancer Injection in Children with Thrombocytopenia | MT |
Sales 2023 | 7.82B 1.08B 86.03B | Sales 2024 * | 8.66B 1.2B 95.33B | Capitalization | 14.66B 2.03B 161B |
---|---|---|---|---|---|
Net income 2023 | 1.55B 214M 17.05B | Net income 2024 * | 1.94B 268M 21.32B | EV / Sales 2023 | 2.37 x |
Net Debt 2023 | 2.15B 297M 23.65B | Net Debt 2024 * | 830M 115M 9.14B | EV / Sales 2024 * | 1.79 x |
P/E ratio 2023 |
11
x | P/E ratio 2024 * |
8.08
x | Employees | - |
Yield 2023 * |
2.61% | Yield 2024 * |
3.54% | Free-Float | 73.92% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 61 | 31/12/92 |
Xiang He
DFI | Director of Finance/CFO | - | 02/07/23 |
Dong Mei Su
BRD | Director/Board Member | 54 | 10/06/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bin Huang
BRD | Director/Board Member | 63 | 31/12/92 |
Jing Lou
CEO | Chief Executive Officer | 61 | 31/12/92 |
Dong Mei Su
BRD | Director/Board Member | 54 | 10/06/12 |
1st Jan change | Capi. | |
---|---|---|
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-12.92% | 32.81B | |
+54.56% | 25B | |
-16.51% | 15.29B | |
-8.27% | 12.93B | |
-42.60% | 11.61B | |
-12.82% | 11.49B | |
+7.34% | 8.98B |